257 related articles for article (PubMed ID: 35549947)
1. All-in-one approaches for triple-negative breast cancer therapy: metal-phenolic nanoplatform for MR imaging-guided combinational therapy.
Xie Q; Li S; Feng X; Shi J; Li Y; Yuan G; Yang C; Shen Y; Kong L; Zhang Z
J Nanobiotechnology; 2022 May; 20(1):226. PubMed ID: 35549947
[TBL] [Abstract][Full Text] [Related]
2. Tumor Cell Targeting and Responsive Nanoplatform for Multimodal-Imaging Guided Chemodynamic/Photodynamic/Photothermal Therapy toward Triple Negative Breast Cancer.
Li L; Li J; Hu R; Zhang X; Ding L; Ren G; Liu W; Wang H; Wang B; Zhang C; Diao H
ACS Appl Mater Interfaces; 2023 Jun; 15(23):27706-27718. PubMed ID: 37261936
[TBL] [Abstract][Full Text] [Related]
3. NIR-laser-triggered gadolinium-doped carbon dots for magnetic resonance imaging, drug delivery and combined photothermal chemotherapy for triple negative breast cancer.
Jiang Q; Liu L; Li Q; Cao Y; Chen D; Du Q; Yang X; Huang D; Pei R; Chen X; Huang G
J Nanobiotechnology; 2021 Mar; 19(1):64. PubMed ID: 33653352
[TBL] [Abstract][Full Text] [Related]
4. Clearable Theranostic Platform with a pH-Independent Chemodynamic Therapy Enhancement Strategy for Synergetic Photothermal Tumor Therapy.
Chen Q; Luo Y; Du W; Liu Z; Zhang S; Yang J; Yao H; Liu T; Ma M; Chen H
ACS Appl Mater Interfaces; 2019 May; 11(20):18133-18144. PubMed ID: 31046230
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional FeS
Feng M; Li M; Dai R; Xiao S; Tang J; Zhang X; Chen B; Liu J
Biomater Sci; 2021 Dec; 10(1):258-269. PubMed ID: 34850790
[TBL] [Abstract][Full Text] [Related]
7. Ellagic acid-Fe@BSA nanoparticles for endogenous H
Tian Q; An L; Tian Q; Lin J; Yang S
Theranostics; 2020; 10(9):4101-4115. PubMed ID: 32226542
[No Abstract] [Full Text] [Related]
8. A Multifunctional, Highly Biocompatible, and Double-Triggering Caramelized Nanotheranostic System Loaded with Fe
Wang F; Li N; Wang W; Ma L; Sun Y; Wang H; Zhan J; Yu D
Int J Nanomedicine; 2023; 18():881-897. PubMed ID: 36844435
[TBL] [Abstract][Full Text] [Related]
9. Holmium (III)-doped multifunctional nanotheranostic agent for ultra-high-field magnetic resonance imaging-guided chemo-photothermal tumor therapy.
Zhang R; Liu M; Liu S; Liang X; Lu R; Shuai X; Wu D; Cao Z
Acta Biomater; 2023 Dec; 172():454-465. PubMed ID: 37863345
[TBL] [Abstract][Full Text] [Related]
10. Facile synthesis of near-infrared responsive on-demand oxygen releasing nanoplatform for precise MRI-guided theranostics of hypoxia-induced tumor chemoresistance and metastasis in triple negative breast cancer.
Zhang D; You Y; Xu Y; Cheng Q; Xiao Z; Chen T; Shi C; Luo L
J Nanobiotechnology; 2022 Mar; 20(1):104. PubMed ID: 35246149
[TBL] [Abstract][Full Text] [Related]
11. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment responsive Mn
Li H; Cai X; Yi T; Zeng Y; Ma J; Li L; Pang L; Li N; Hu H; Zhan Y
J Nanobiotechnology; 2022 May; 20(1):240. PubMed ID: 35606848
[TBL] [Abstract][Full Text] [Related]
13. Indocyanine Green-Based Theranostic Nanoplatform for NIR Fluorescence Image-Guided Chemo/Photothermal Therapy of Cervical Cancer.
Ma R; Alifu N; Du Z; Chen S; Heng Y; Wang J; Zhu L; Ma C; Zhang X
Int J Nanomedicine; 2021; 16():4847-4861. PubMed ID: 34305398
[TBL] [Abstract][Full Text] [Related]
14. Smart Manganese Dioxide-Based Lanthanide Nanoprobes for Triple-Negative Breast Cancer Precise Gene Synergistic Chemodynamic Therapy.
Ming L; Song L; Xu J; Wang R; Shi J; Chen M; Zhang Y
ACS Appl Mater Interfaces; 2021 Aug; 13(30):35444-35455. PubMed ID: 34292714
[TBL] [Abstract][Full Text] [Related]
15. Bovine serum albumin-templated nanoplatform for magnetic resonance imaging-guided chemodynamic therapy.
Tang W; Gao H; Ni D; Wang Q; Gu B; He X; Peng W
J Nanobiotechnology; 2019 May; 17(1):68. PubMed ID: 31109332
[TBL] [Abstract][Full Text] [Related]
16. Polypyrrole-based nanotheranostic agent for MRI guided photothermal-chemodynamic synergistic cancer therapy.
Zhou B; Yin C; Feng Q; Wu Y; Pan X; Liu C; Tian J; Geng S; Wang K; Xing J; Cao Y; Shou P; Yu Z; Wu A
Nanoscale; 2021 Nov; 13(45):19085-19097. PubMed ID: 34761764
[TBL] [Abstract][Full Text] [Related]
17. Treatment of triple negative breast cancer by near infrared light triggered mild-temperature photothermal therapy combined with oxygen-independent cytotoxic free radicals.
Li R; Hu X; Shang F; Wu W; Zhang H; Wang Y; Pan J; Shi S; Dong C
Acta Biomater; 2022 Aug; 148():218-229. PubMed ID: 35705171
[TBL] [Abstract][Full Text] [Related]
18. BSA-based Cu
Liu Z; Chan L; Ye X; Bai Y; Chen T
Colloids Surf B Biointerfaces; 2018 Dec; 172():298-307. PubMed ID: 30173097
[TBL] [Abstract][Full Text] [Related]
19. NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform.
Shen X; Li T; Chen Z; Xie X; Zhang H; Feng Y; Li S; Qin X; Yang H; Wu C; Zheng C; Zhu J; You F; Liu Y
Mol Pharm; 2019 Mar; 16(3):1367-1384. PubMed ID: 30776896
[TBL] [Abstract][Full Text] [Related]
20. A uPAR targeted nanoplatform with an NIR laser-responsive drug release property for tri-modal imaging and synergistic photothermal-chemotherapy of triple-negative breast cancer.
Yu S; Huang G; Yuan R; Chen T
Biomater Sci; 2020 Jan; 8(2):720-738. PubMed ID: 31777866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
